Scientists have made an advancement in the field of electrocatalysis. Their latest research, published in the journal Nature ...
These shifts highlight specific molecular mechanisms, such as immune activation and structural integrity decline, across various cell types. These findings could help reveal brain regions and ...
Tuspetinib (TUS) is a well-tolerated, once daily, oral kinase inhibitor in clinical development for treatment of acute myeloid leukemia (AML). Nonclinical studies show that TUS targets key prosurvival ...
Molecular Cancer Research publishes articles featuring novel, basic cancer research discoveries that prioritize broad molecular and cellular processes. Areas of emphasis include cell cycle and ...